reproductive healthcare

In 2000, the F.D.A. approved the medication abortion drug mifepristone. Now a federal judge in Texas is set to rule on a case filed by anti-abortion groups urging the agency to revoke its approval of mifepristone and the other main drug used for medication abortion in the United States. Abortion via medication has become increasingly common and now accounts for more than half of the nation’s abortions.

Plus, the Biden administration has started talking publicly about its intelligence when it comes to China, breaking with a long tradition of keeping U.S. secrets close to the chest. The secretary of state, the director of the C.I.A. and even the president himself have made statements on TV expressing concern over China’s plans to help Russia in the war in Ukraine.

Guest: Pam Belluck, a health and science correspondent for The New York Times.

Julian E. Barnes, a national security correspondent for The Times.

Background reading: 

• Twelve states have sued the F.D.A. seeking removal of special restrictions on abortion pills. The suit argues that rules applying to mifepristone unnecessarily limit patients’ access to medication abortion.
• Bolder intelligence disclosures are part of a larger effort to stymie the Kremlin’s offensive in Ukraine and align support for Kyiv’s war effort in allied countries.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

In the days since the Supreme Court overturned Roe v. Wade, states have rushed to either ban, restrict or protect abortion.

The different approaches have created a fragmented, patchwork map of America.

Guest: Margot Sanger-Katz, a domestic correspondent covering health care for The New York Times.

Want more from The Daily? For one big idea on the news each week from our team, subscribe to our newsletter. 

Background reading: 

• With Roe overturned, the distances many women will need to travel for an abortion will increase drastically.
• Here are answers to some of the fundamental questions about the ramifications of the justices’ decision.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.